NHT
TMO icon

New Hampshire Trust’s Thermo Fisher Scientific TMO Stock Holding History

New Hampshire Trust’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.57M Sell
7,119
-50
-0.7% -$24K 0.67% 41
2026
Q1 		$3.52M Buy
7,169
+319
+5% +$173K 0.71% 46
2025
Q4 		$3.97M Sell
6,850
-308
-4% -$174K 0.77% 42
2025
Q3 		$3.47M Buy
7,158
+445
+7% +$207K 0.67% 41
2025
Q2 		$2.72M Buy
6,713
+32
+0.5% +$13.4K 0.57% 50
2025
Q1 		$3.32M Buy
6,681
+314
+5% +$170K 0.76% 36
2024
Q4 		$3.31M Buy
6,367
+46
+0.7% +$25.3K 0.7% 43
2024
Q3 		$3.91M Sell
6,321
-33
-0.5% -$19.5K 0.84% 35
2024
Q2 		$3.51M Buy
6,354
+86
+1% +$49.3K 0.8% 37
2024
Q1 		$3.64M Buy
6,268
+69
+1% +$38.7K 0.85% 37
2023
Q4 		$3.29M Sell
6,199
-121
-2% -$58.6K 0.79% 38
2023
Q3 		$3.2M Buy
6,320
+73
+1% +$38.9K 0.87% 34
2023
Q2 		$3.26M Sell
6,247
-152
-2% -$82K 0.85% 33
2023
Q1 		$3.69M Sell
6,399
-421
-6% -$237K 0.99% 25
2022
Q4 		$3.76M Buy
+6,820
New +$3.61M 0.99% 26

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

New Hampshire Trust's TMO Position: Q2 2026 in Review

New Hampshire Trust reduced its Thermo Fisher Scientific (TMO) stake by 0.7% in Q2 2026, selling an estimated $24K and leaving 7,119 shares worth $3.57M. The position accounts for 0.67% of the portfolio, ranked #41.

New Hampshire Trust first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.97M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • New Hampshire Trust held 7,119 shares of Thermo Fisher Scientific worth $3.57M as of Q2 2026.
  • New Hampshire Trust sold 50 Thermo Fisher Scientific shares in Q2 2026, an estimated $24K.
  • Thermo Fisher Scientific made up 0.67% of New Hampshire Trust's portfolio in Q2 2026, its #41 holding.
  • New Hampshire Trust first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • New Hampshire Trust's Thermo Fisher Scientific position peaked at $3.97M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on New Hampshire Trust's 13F filing for Q2 2026, filed 27 Jul 2026.